ProMIS Neurosciences, Inc.
PMN
$7.55
$0.111.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 28.34M | 21.10M | 13.98M | 10.64M | 8.54M |
| Gross Profit | -28.34M | -21.10M | -13.98M | -10.64M | -8.54M |
| SG&A Expenses | 3.56M | 3.48M | 3.13M | 2.69M | 6.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.90M | 24.58M | 17.11M | 13.33M | 14.70M |
| Operating Income | -31.90M | -24.58M | -17.11M | -13.33M | -14.70M |
| Income Before Tax | -29.28M | -8.43M | -934.00K | 2.78M | -563.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.28 | -8.43 | -0.93 | 2.78 | -0.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.28M | -8.43M | -934.00K | 2.78M | -563.40K |
| EBIT | -31.90M | -24.58M | -17.11M | -13.33M | -14.70M |
| EBITDA | -2.50M | -6.93M | -9.64M | -13.31M | -14.67M |
| EPS Basic | -18.63 | -4.98 | -1.04 | -0.42 | -4.82 |
| Normalized Basic EPS | -10.07 | -1.54 | 0.92 | 1.31 | -3.01 |
| EPS Diluted | -18.70 | -4.98 | -1.04 | -0.42 | -4.82 |
| Normalized Diluted EPS | -10.07 | -1.55 | 0.92 | 1.30 | -3.02 |
| Average Basic Shares Outstanding | 6.13M | 5.38M | 4.78M | 4.17M | 3.56M |
| Average Diluted Shares Outstanding | 6.13M | 5.38M | 4.78M | 4.17M | 3.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |